Us Bancorp »

Inozyme Pharma shares owned by Us Bancorp

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Us Bancorp

Quarter filed Position value Share count Share price at filing
2024-09-30 $230 44 5.23
2023-09-30 $542 129 4.20

More positions owned by Us Bancorp

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Rus Mid Cap Etf (IWR)
Eli Lilly & Co. (LLY)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
NVIDIA Corporation (NVDA)
JPMorgan Chase & Co. (JPM)

View all positions for Us Bancorp

Top funds holding Inozyme Pharma

Adage Capital Partners GP
Pivotal bioVenture Partners Investment Advisor
Sofinnova Ventures
Affinity Asset Advisors
Rock Springs Capital Management
BlackRock
Vanguard Group
NEA Management Company
Eventide Asset Management
Millennium Management
FMR
Samsara BioCapital
Saturn V Capital Management
Sphera Funds Management
Geode Capital Management

View all funds holding Inozyme Pharma